Case Report: A Case of Locally Advanced Pancreatic Cancer Which Achieved Progression Free for over 12 Months by Subsequent Therapy with Anlotinib Hydrochloride Plus Tegafur-Gimeracil-Oteracil Potassium (TS-1)
Frontiers in oncology（2022）
关键词
advanced pancreatic cancer,anlotinib,TS-1,gimeracil and oteracil potassium capsules,targeted therapy,chemotherapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要